Myoclonic Epilepsy
📧 Sign up to get email alerts when something new happens for Myoclonic Epilepsy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-08EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.
The EMA authorised Fintepla (fenfluramine hydrochloride) from UCB Pharma S.A. for epilepsies with myoclonic seizures, an orphan medicine des…
-
EMA approval · 2026-04-09EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.
The EMA authorised Fintepla (fenfluramine hydrochloride) for epilepsies with myoclonic features, with orphan medicine designation; decision …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies
Clinical trial update describing an extended access program using lorcaserin to treat Dravet syndrome and other refractory epilepsies.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Effect of Levetiracetam on Brain Excitability
A clinical trial investigated the effect of the antiepileptic drug levetiracetam on brain excitability in healthy participants and individua…